Lennart Minthon

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

Oskar Hansson, Henrik Zetterberg, Peder Buchhave et al. · The Lancet Neurology · 2006 · 1.7K citations · Full text

Alzheimer's Disease, Csf Biomarkers, Dementia +10

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Sandip Ray, Markus Britschgi, Charles Herbert et al. · Nature Medicine · 2007 · 1.1K citations

Alzheimer's Disease, Medicine, Dementia +11

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease

Niels Andreasen, Camilla Hesse, Pia Davidsson et al. · Archives of Neurology · 1999 · 658 citations

¹⁸F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial

Rik Vandenberghe, Koen Van Laere, Adrian Ivanoiu et al. · Annals of Neurology · 2010 · 636 citations

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

Pieter Jelle Visser, Frans R.J. Verhey, Dirk L. Knol et al. · The Lancet Neurology · 2009 · 617 citations

Neuropsychology, Alzheimer's Disease, Psychiatry +8